直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • Articles & Books
    • Ad Law Buzz Blog
    • At the PTAB Blog
    • European IP Blog
    • Federal Circuit IP Blog
    • INCONTESTABLE® Blog
    • Prosecution First Blog
  • Events & Webinars
  • IP Updates
  • Podcasts
    • AI + Finnegan
    • AI + Copyright
    • AI + Patent
    • AI + Privacy
    • AI + Trade Secrets
    • AI + Trademark
  • Unified Patent Court (UPC) Hub

At the PTAB Blog

Federal Circuit Clarifies the Burden of Proof in Magnum Oil

August 10, 2016

Authored and Edited by Shayda Shahbazi; Aaron J. Capron

In its recent decision, In re Magnum Oil Tools International, No. 2015-1300, the Federal Circuit clarified the burden of proof for IPR proceedings. In particular, it held that the PTAB improperly shifted the burden of proof to the patent owner to disprove obviousness.

When filing its petition with the PTAB, McClinton argued that the claims at issue would have been obvious over a first and second set of prior art. While McClinton and its expert appeared to have fully addressed the first set of prior art, they only “incorporated by reference” the arguments from the first set onto the second set of prior art. In responding, patent owner Magnum contended, among other things, that McClinton’s analysis for the second set of prior art failed to “specify where each element of the claim is found” and to describe how a skilled artisan would have modified the second set of prior art. Despite these shortcomings, the PTAB found that McClinton had established a reasonable likelihood of success based on only the second set of prior art and instituted the IPR. Relying on that analysis in the Final Written Decision, the PTAB held that the claims at issue were invalid as being obvious over the second set of art.

Subsequently, McClinton and Magnum settled the dispute, in which McClinton agreed to not participate in any appeal.

Appeal

On appeal, Magnum argued that the “PTAB erred in cancelling the claims at issue because ‘neither McClinton nor the [PTAB] ever established a prima facie basis for the rejection’” for the second set of prior art. By doing such, Magnum contended that the PTAB improperly shifted the burden of proof to Magnum. The PTO intervened, alleging that the burden of producing nonobviousness evidence shifted to the patent owner when the PTAB found a reasonable likelihood of success in its Institution Decision. It reasoned that once the PTAB found a reasonable likelihood that McClinton would ultimately carry its burden of persuasion, the burden of production shifted to Mangum to argue or produce evidence indicating otherwise.

To begin its analysis, the Federal Circuit stated that the burden of proof involves two burdens: The burden of persuasion and the burden of production. “The burden of persuasion ‘is the ultimate burden assigned to a party who must prove something to a specified degree of certainty’ [while] the burden of production may entail ‘producing additional evidence and presenting persuasive argument based on new evidence or evidence already on the record.’”

Regarding the burden of persuasion, the Court held that the ultimate burden must remain on the patent challenger and that burden-shifting is not suitable. The Court further held that “the petitioner continues to bear the burden of proving unpatentability after institution, and must do so by preponderance of the evidence at trial.”

Regarding the burden of production, the Federal Circuit disagreed with the PTO’s proposed burden of production shifting from the petitioner to the patent owner upon the PTAB’s conclusion in an institution decision that “there is reasonable likelihood that the petitioner would prevail.” The Court held that the PTO’s proposed shifting of the burden would be directly at odds with precedent holding that the institution decision and the final written decision are two different analyses and each applies a qualitatively different standard. Accordingly, the Court held that the petitioner continues to bear the burden of proving unpatentability after institution, and must do so by a preponderance of the evidence at trial.

Relying on that analysis, the Federal Circuit reversed the PTAB decision, concluding that the PTAB had improperly shifted the burden to Magnum as McClinton only provided “conclusory statements” without “articulat[ing] specific reasons, based on evidence of record to support the legal conclusion of obviousness” over the second set of prior art. Moreover, it explicitly rejected the PTO’s position that the PTAB is free to adopt arguments on behalf of petitioners that could have been, but were not, raised by the petitioner. That is, the PTAB “must base its decision on arguments that were advanced by a party, and to which the opposing party was given a chance to respond.”

 

*Shayda Shahbazi is a Technical Specialist at Finnegan

Tags

combining references, United States Court of Appeals for the Federal Circuit (CAFC), Obviousness (35 USC § 103), Person of Ordinary Skill in the Art (PHOSITA)

Related Practices

Patent Office Invalidation Proceedings

PTAB Invalidation Proceedings: IPR and PGR

Contacts

Aaron J. Capron
Partner
Palo Alto, CA
+1 650 849 6680
Email

Copyright © 2016 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP. 

DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. Additional disclaimer information.

Related Insights

Conference

7th International Conference on Biofuels and Bioenergy

June 25-26, 2026

Edinburgh

Conference

17th Summit on Biosimilars & Innovator Biologics

June 2-3, 2026

New York

At the PTAB Blog

Discretion All the Way Down: USPTO Uses a Discretionary IPR Denial to Justify a    
§ 325(d) EPR Denial

May 28, 2026

Articles

Colorado Replaces Landmark AI Act: An Overview of the New SB 26-189 Framework

May 26, 2026

At the PTAB Blog

IPR and PGR Statistics for Final Written Decisions Issued in March and April 2026

May 26, 2026

At the PTAB Blog

Claim Disclaimer Derails Instituted IPR in Freightcar America

May 26, 2026

At the PTAB Blog

Before the Holding, the Message: Director Squires Uses Magnolia Medical to Outline PTAB Discretionary Denial Policy Changes

May 20, 2026

Conference

19th Annual Forum on Pharma & Biotech Patent Litigation in Europe

May 19-20, 2026

Amsterdam

Webinar

Changes at the PTAB from Settled Expectations to Real Parties in Interest to Director Involvement

May 18, 2026

Webinar

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP